Project: Development of novel non-invasive diagnostic tests to detect lymphomas
| Acronym | LyMoDx (Reference Number: 10880) |
| Duration | 01/01/2017 |
| Project Topic | LyMoDx will deliver a novel in vitro diagnostic (IVD) test to detect cancer in blood. Cells release extracellular vesicles (EV) containing distinct RNA fingerprints into the blood; the EV-based RNA fingerprint for lymphoma will be technically validated, tested in a proof-of-concept study and offered as a diagnostic service to pharma, while being further developed into an in vitro diagnostic test (IVD). The consortium will perform full clinical studies directly after the project end. |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 6 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | ExBiome BV | Coordinator | Netherlands |
| 2 | Eagle Genomics Ltd | Partner | United Kingdom |
| 3 | ExScale Biospecimen Solutions AB | Partner | Sweden |
| 4 | Izon Science Europe Ltd. | Partner | United Kingdom |
| 5 | Uppsala University | Partner | Sweden |